Literature DB >> 23815527

Mechanosignaling in bone health, trauma and inflammation.

Derrick M Knapik1, Priyangi Perera, Jin Nam, Alisa D Blazek, Björn Rath, Binnaz Leblebicioglu, Hiranmoy Das, Lai Chu Wu, Timothy E Hewett, Suresh K Agarwal, Alexander G Robling, David C Flanigan, Beth S Lee, Sudha Agarwal.   

Abstract

SIGNIFICANCE: Mechanosignaling is vital for maintaining the structural integrity of bone under physiologic conditions. These signals activate and suppress multiple signaling cascades regulating bone formation and resorption. Understanding these pathways is of prime importance to exploit their therapeutic potential in disorders associated with bone loss due to disuse, trauma, or disruption of homeostatic mechanisms. RECENT ADVANCES: In the case of cells of the bone, an impressive amount of data has been generated that provides evidence of a complex mechanism by which mechanical signals can maintain or disrupt cellular homeostasis by driving transcriptional regulation of growth factors, matrix proteins and inflammatory mediators in health and inflammation. Mechanical signals act on cells in a magnitude dependent manner to induce bone deposition or resorption. During health, physiological levels of these signals are essential for maintaining bone strength and architecture, whereas during inflammation, similar signals can curb inflammation by suppressing the nuclear factor kappa B (NF-κB) signaling cascade, while upregulating matrix synthesis via mothers against decapentaplegic homolog and/or Wnt signaling cascades. Contrarily, excessive mechanical forces can induce inflammation via activation of the NF-κB signaling cascade. CRITICAL ISSUES: Given the osteogenic potential of mechanical signals, it is imperative to exploit their therapeutic efficacy for the treatment of bone disorders. Here we review select signaling pathways and mediators stimulated by mechanical signals to modulate the strength and integrity of the bone. FUTURE DIRECTIONS: Understanding the mechanisms of mechanotransduction and its effects on bone lay the groundwork for development of nonpharmacologic mechanostimulatory approaches for osteodegenerative diseases and optimal bone health.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23815527      PMCID: PMC3924811          DOI: 10.1089/ars.2013.5467

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  131 in total

Review 1.  Regulation of NF-κB by ubiquitination and degradation of the IκBs.

Authors:  Naama Kanarek; Yinon Ben-Neriah
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

Review 2.  Mechanisms by which exercise improves bone strength.

Authors:  Charles H Turner; Alexander G Robling
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

3.  The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.

Authors:  Kimihiko Sawakami; Alexander G Robling; Minrong Ai; Nathaniel D Pitner; Dawei Liu; Stuart J Warden; Jiliang Li; Peter Maye; David W Rowe; Randall L Duncan; Matthew L Warman; Charles H Turner
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

Review 4.  Mechanotransduction in osteoblast regulation and bone disease.

Authors:  Katerina K Papachroni; Demetrios N Karatzas; Kostas A Papavassiliou; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  Trends Mol Med       Date:  2009-04-08       Impact factor: 11.951

5.  Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3.

Authors:  Jong Seok Kang; Tamara Alliston; Rachel Delston; Rik Derynck
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

Review 6.  Skeletal muscle hypertrophy and atrophy signaling pathways.

Authors:  David J Glass
Journal:  Int J Biochem Cell Biol       Date:  2005-10       Impact factor: 5.085

7.  Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo.

Authors:  M R Forwood
Journal:  J Bone Miner Res       Date:  1996-11       Impact factor: 6.741

8.  Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells.

Authors:  Xian Fan; Eileen Roy; Liping Zhu; Tamara C Murphy; Cheryl Ackert-Bicknell; C Michael Hart; Clifford Rosen; Mark S Nanes; Janet Rubin
Journal:  Endocrinology       Date:  2003-10-16       Impact factor: 4.736

9.  Mechanobiology of the skeleton.

Authors:  Charles H Turner; Stuart J Warden; Teresita Bellido; Lilian I Plotkin; Natarajan Kumar; Iwona Jasiuk; Jon Danzig; Alexander G Robling
Journal:  Sci Signal       Date:  2009-04-28       Impact factor: 8.192

10.  Lrp5 functions in bone to regulate bone mass.

Authors:  Yajun Cui; Paul J Niziolek; Bryan T MacDonald; Cassandra R Zylstra; Natalia Alenina; Daniel R Robinson; Zhendong Zhong; Susann Matthes; Christina M Jacobsen; Ronald A Conlon; Robert Brommage; Qingyun Liu; Faika Mseeh; David R Powell; Qi M Yang; Brian Zambrowicz; Han Gerrits; Jan A Gossen; Xi He; Michael Bader; Bart O Williams; Matthew L Warman; Alexander G Robling
Journal:  Nat Med       Date:  2011-05-22       Impact factor: 53.440

View more
  15 in total

1.  Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification.

Authors:  Shailesh Agarwal; Shawn J Loder; Christopher Breuler; John Li; David Cholok; Cameron Brownley; Jonathan Peterson; Hsiao H Hsieh; James Drake; Kavitha Ranganathan; Yashar S Niknafs; Wenzhong Xiao; Shuli Li; Ravindra Kumar; Ronald Tompkins; Michael T Longaker; Thomas A Davis; Paul B Yu; Yuji Mishina; Benjamin Levi
Journal:  Mol Ther       Date:  2017-07-15       Impact factor: 11.454

2.  Follistatin-like 3 is a mediator of exercise-driven bone formation and strengthening.

Authors:  J Nam; P Perera; R Gordon; Y H Jeong; A D Blazek; D G Kim; B C Tee; Z Sun; T D Eubank; Y Zhao; B Lablebecioglu; S Liu; A Litsky; N L Weisleder; B S Lee; T Butterfield; A L Schneyer; S Agarwal
Journal:  Bone       Date:  2015-04-30       Impact factor: 4.398

Review 3.  Musculoskeletal Health in the Context of Spinal Cord Injury.

Authors:  Jillian M Clark; David M Findlay
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

Review 4.  Metabolic underpinnings of leukemia pathology and treatment.

Authors:  Travis Nemkov; Angelo D'Alessandro; Julie A Reisz
Journal:  Cancer Rep (Hoboken)       Date:  2018-10-07

5.  Control of the Osteoblast Lineage by Mitogen-Activated Protein Kinase Signaling.

Authors:  Renny T Franceschi; Chunxi Ge
Journal:  Curr Mol Biol Rep       Date:  2017-04-25

6.  NF-κB inhibitor, NEMO-binding domain peptide attenuates intervertebral disc degeneration.

Authors:  Juliane D Glaeser; Khosrowdad Salehi; Linda E A Kanim; Zachary NaPier; Michael A Kropf; Jason M Cuéllar; Tiffany G Perry; Hyun W Bae; Dmitriy Sheyn
Journal:  Spine J       Date:  2020-05-12       Impact factor: 4.166

Review 7.  P2X7Rs: new therapeutic targets for osteoporosis.

Authors:  Haoyun Huang; Yu-Mei He; Miao-Miao Lin; Yanchao Wang; Xiaomei Zhang; Li Liang; Xueling He
Journal:  Purinergic Signal       Date:  2022-02-02       Impact factor: 3.765

Review 8.  Mechanotransduction in Wound Healing and Fibrosis.

Authors:  Britta Kuehlmann; Clark A Bonham; Isabel Zucal; Lukas Prantl; Geoffrey C Gurtner
Journal:  J Clin Med       Date:  2020-05-11       Impact factor: 4.241

Review 9.  Mechanical basis of bone strength: influence of bone material, bone structure and muscle action.

Authors:  N H Hart; S Nimphius; T Rantalainen; A Ireland; A Siafarikas; R U Newton
Journal:  J Musculoskelet Neuronal Interact       Date:  2017-09-01       Impact factor: 2.041

10.  Sacroiliac Joint Asymmetry Regarding Inflammation and Bone Turnover: Assessment by FDG and NaF PET/CT.

Authors:  Abdullah Al-Zaghal; Dani P Yellanki; Esha Kothekar; Thomas J Werner; Poul F Høilund-Carlsen; Abass Alavi
Journal:  Asia Ocean J Nucl Med Biol       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.